Company Search:
Advanced Search
Sponsored Links
Immuno-Biological Laboratories Company Limited Company Snapshot
Immuno-Biological Laboratories Company Limited operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immuno-Biological Laboratories Company Limited with three other drug stores in Asia: FCW Holdings Berhad of Malaysia (2016 sales of 26.57 million Malaysian Ringgits [US$6.00 million] of which 100% was Wholesale), Muller and Phipps (Ceylon) Plc of Sri Lanka (903.25 million Sri Lanka Rupees [US$5.95 million] ), and Ibl Healthcare Limited which is based in Pakistan (1.16 billion Pakistan Rupees [US$11.04 million] ).

Sales Analysis. During the year ended March of 2016, sales at Immuno-Biological Laboratories Company Limited were ¥717.66 million (US$6.44 million). This is a decrease of 1.6% versus 2015, when the company's sales were ¥729.03 million. Contributing to the drop in overall sales was the 37.4% decline in Cosmetics Related Business, from ¥25.21 million to ¥15.79 million. There were also decreases in sales in Examine Business (down 0.1% to ¥109.74 million) and Recombinant Silkworm (down 25.1% to ¥67.41 million) . However, these declines were partially offset by the increase in sales of Diagnosis and Reagent (up 4.1% to ¥524.72 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Immuno-Biological Laboratories Company Limited
  Stock Performance Chart for Immuno-Biological Laboratories Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 835.00
(Figures in Japanese Yen)
1 Week -4.0%   13 Weeks 4.5%  
4 Weeks 4.6%   52 Weeks -15.4%  
Immuno-Biological Laboratories Company Limited Key Data:
  Ticker: 4570 Country: Japan
  Exchanges: TYO JSQ Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2016 Sales 717,661,000
(Year Ending Jan 2017).
Employees: 54
  Currency: Japanese Yen Market Cap: 6,121,769,100
  Fiscal Yr Ends: March Shares Outstanding: 7,331,460
  Share Type: Common Closely Held Shares: 2,041,700
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.